0.7033

0.00% 0.00

Skye Bioscience Inc (SKYE)

Overview News Price History Discussions Forecast

Skye Bioscience Inc stock is traded at $0.7033, with a volume of 61,681. It is up +0.00% in the last 24 hours and down -4.08% over the past month. Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Previous Close:

$0.7033

Open:

$0.7033

24h Volume:

61,681

Relative Volume:

0.34

Market Cap:

$24.72M

Revenue:

Net Income/Loss:

$-57.33M

P/E Ratio:

-0.4866

EPS:

-1.4452

Net Cash Flow:

$-42.44M

1W Performance:

+1.44%

1M Performance:

-4.08%

6M Performance:

-36.64%

1Y Performance:

-83.98%

1-Day Range:

$0.7033

$0.7193

1-Week Range:

$0.675

$0.7193

52-Week Range:

$0.5655

$4.9902

Skye Bioscience Inc Stock (SKYE) Company Profile

Name

Skye Bioscience Inc

Sector

Healthcare (1094)

Industry

Biotechnology (615)

Phone

(858) 410-0266

Address

11250 EL CAMINO REAL, SUITE 100, SAN DIEGO

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

SKYE's Discussions on Twitter

Compare SKYE vs MOBBW, GOODO, PSNYW, SHMD, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SKYE Skye Bioscience Inc.	3.10	12.89M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	2.49	2.97B	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.01	372.90M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	2.20	349.09M	2.07B	-1.42B	-1.37B	-0.6765
SHMD Schmid Group N V	4.72	358.07M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	47.37	0	0	0	0	0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-06-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Oct-06-25	Downgrade	Craig Hallum	Buy → Hold
Aug-15-25	Initiated	Evercore ISI	Outperform
Feb-28-25	Initiated	William Blair	Outperform
Sep-30-24	Initiated	Scotiabank	Sector Outperform
Sep-10-24	Initiated	JMP Securities	Mkt Outperform
Jul-09-24	Initiated	Craig Hallum	Buy
May-23-24	Initiated	Cantor Fitzgerald	Overweight
Apr-12-24	Initiated	Oppenheimer	Outperform

View All

Skye Bioscience Inc Stock (SKYE) Latest News

Jul 01, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Skye Bioscience, In - The National Law Review

Jul 01, 2026

Skye Bioscience, Inc. Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jun 27, 2026

Price to earnings forward of Skye Bioscience, Inc. – NASDAQ:SKYE - TradingView

Jun 27, 2026

Enterprise value to revenue forward of Skye Bioscience, Inc. – NASDAQ:SKYE - TradingView

Jun 27, 2026

Jun 26, 2026

Price to book forward of Skye Bioscience, Inc. – NASDAQ:SKYE - TradingView

Jun 26, 2026

Enterprise value to EBIT forward of Skye Bioscience, Inc. – NASDAQ:SKYE - TradingView

Jun 26, 2026

Skye Bioscience to Move Listing to Nasdaq Capital Market After Equity Shortfall - TradingView

Jun 23, 2026

Skye Bioscience (NASDAQ: SKYE) shifts to Nasdaq Capital Market amid listing notices - Stock Titan

Jun 23, 2026

Jun 22, 2026